Table 1.
Comparison of data between the FR and successful recanalization groups
| successful recanalization group (n = 57) | FR group (n = 139) | P-value | ||
|---|---|---|---|---|
| Age, years, median (range) | 65.0 (29.0–90.0) | 71.0 (28.0–95.0) | 0.01* | |
| Sex, male, n (%) | 33 (57.9) | 73 (52.5) | 0.49 | |
| Hypertension, n (%) | 19 (33.3) | 76 (54.7) | 0.007* | |
| Diabetes, n (%) | 6 (10.5) | 33 (23.7) | 0.035* | |
| Atrial fibrillation, n (%) | 14 (24.6) | 40 (28.8) | 0.55 | |
| Smoking, n (%) | 18 (31.6) | 31 (22.3) | 0.17 | |
| ASPECT, median (range) | 7.74(0–10) | 6(0–9) | 0.118 | |
| NIHSS, median (range) | 12.0 (3.0–35.0) | 18.0 (3.0–35.0) | 0.00* | |
| Site of occlusion | ||||
| ICA, n (%) | 17 (29.8) | 47 (33.8) | 0.84 | |
| M1, n (%) | 37 (64.9) | 83 (59.7) | ||
| Tandem, n (%) | 3 (5.3) | 9 (6.5) | ||
| Direct thrombectomy, n (%) | 19 (33.3) | 37 (26.6) | 0.35 | |
| Endovascular treatment modalities | ||||
| Stenting, n (%) | 22 (38.6) | 72 (51.8) | 0.130 | |
| Aspiration, n (%) | 18 (31.6) | 27 (19.4) | ||
| Aspiration + Stenting, n (%) | 17 (29.8) | 40 (28.8) | ||
| CRP (mg/L) median (range) | 3.24 (0.25–42.24) | 6.14 (0.34-143.11) | 0.00* | |
| Lymphocytes (10^9/L) median (range) | 1.34 (0.41–2.66) | 0.96 (0.22–7.33) | 0.00* | |
| Neutrophils (10^9/L) median (range) | 5.27 (2.67–14.43) | 7.67 (0.42–27.89) | 0.00* | |
| Platelet count (10^9/L) median (range) | 184.0 (55.0-367.0) | 169.0 (49.0-415.0) | 0.44 | |
| Monocytes (10^9/L) median (range) | 0.39 (0.13–0.87) | 0.44 (0.02–3.72) | 0.06 | |
| HDLC (mmol/L) median (range) | 1.27 (0.19-2.00) | 1.25 (0.67–2.57) | 0.39 | |
| Total cholesterol (mmol/L) median (range) | 4.10 (2.04–6.34) | 3.95 (1.16–7.40) | 0.54 | |
| Triglycerides (mmol/L) median (range) | 0.88 (0.35–3.09) | 1.01 (0.39–5.92) | 0.46 | |
| LDL (mmol/L) median (range) | 2.35 (0.80–4.71) | 2.07 (0.56–4.93) | 0.19 | |
| NLR, median (range) | 3.98 (1.06–18.78) | 8.32 (0.16–71.16) | 0.00* | |
| MHR, median (range) | 0.29 (0.0-0.74) | 0.35 (0.0-2.53) | 0.037* | |
| LMR, median (range) | 3.55 (1.20-11.41) | 2.00 (0.16–24.50) | 0.00* | |
| LCR, median (range) | 0.57 (0.03–4.47) | 0.16 (0.00-14.50) | 0.00* | |
| LHR, median (range) | 0.93 (0.0–2.0) | 0.94 (0.0–5.0) | 0.99 | |
| procedure duration time (minutes), median (range) | 54.45 (13–115) | 71.48 (16–345) | 0.004* | |
| onset-recanalization time (minutes), median (range) | 425.03 (115–960) | 427.63 (147–1032) | 0.93 | |
Note: ASPECT: Alberta Stroke Program Early CT Score. NIHSS: National Institutes of Health Stroke Scale; ICA: intracranial internal carotid artery; M1: M1 segment of the middle cerebral artery; CRP: C-reactive protein; NLR: neutrophil-to-lymphocyte ratio; MHR: monocyte-to-HDL ratio; LMR: lymphocyte-to-monocyte ratio; LCR: lymphocyte-to-C-reactive protein ratio; LHR: lymphocyte-to-HDL ratio; *: specific signs refer to significant p-value